Vol 4, No 1 (2024)
- Year: 2024
- Articles: 4
- URL: https://journals.rcsi.science/cardar/issue/view/16338
- DOI: https://doi.org/10.17816/cardar.41
Original Research
Opportunities of metabolic treatment in paroxysmal atrial fibrillation patients with obesity, arterial hypertension and/or ischemic heart disease
Abstract
This article provides the experience of examination and treatment of paroxysmal atrial fibrillation patients with concomitant obesity, arterial hypertension and/or ischemic heart disease, who were prescribed levocarnitine in addition to traditional therapy. The addition of levocarnitine in management of atrial fibrillation was found to be capable of reducing the atrial fibrillation burden after cardioversion and improve the functional state of the patients.
5-14
Case reports
First experience of treating patients with atrial fibrillation using thoracoscopic isolation with left atrial appendage excision in the North-Western State Medical University named after I.I. Mechnikov
Abstract
The given article describes the first experience of a thoracoscopic isolation of pulmonary veins and left atrial appendage excision in the North-Western State Medical University named after I.I. Mechnikov. The clinical case features a woman with a long history of paroxysmal atrial fibrillation, severe left atrium dilation, failure in a pace control drug therapy and no effect of radiofrequency catheter isolation of pulmonary veins.
Additionally, there outlined the advantages and the significance of employing the method of thoracoscopic ablation in patients with symptomatic paroxysmal and long-term persistent atrial fibrillation, — in case if antiarrythmic drugs and radiofrequency catheter ablation proved ineffective, as well as in patients with a long-term persistent atrial fibrillation along with a severe left atrium dilation.
15-22
Obstructive sleep apnea as a potentially reversible cause of nighttime bradyarrhythmias. Clinical case
Abstract
Obstructive sleep apnea syndrome is a common condition, especially among obese patients. Patients with obstructive sleep apnea syndrome have an increased risk of developing arterial hypertension and cardiovascular events, as well as cardiac arrhythmias, which include reflexively occurring bradyarrhythmias and episodes of asystole at night. Treatment of obstructive sleep apnea syndrome leads to an improvement in the patient’s quality of life and also reduces cardiovascular risk and eliminates associated bradyarrhythmias during night sleep.
23-30
Multifaces of hypertrophic cardiomyopathy: a case of transformation of hypertrophic phenotype into dilated
Abstract
The article presents a clinical case of a rather rare course of hypertrophic cardiomyopathy with the transformation of a hypertrophic phenotype into a dilated phenotype against the background of the “burned-out phase” phenomenon, ventricular and supraventricular rhythm disturbances, and multiple genetic mutations. Timely started disease-modifying therapy (quadruple therapy) for chronic heart failure led to reverse positive remodeling of the left chambers of the heart.
31-41